Trial intelligence / Profile preview

Ultrasound Hyperthermia with Chemotherapy in Head and Neck Cancer

NCT02353260Phase 2Unknown

Start
Dec 2014
Primary completion
Mar 2016
Countries
1
01

Overview

Phase 2, randomised, open-label trial in head and neck squamous cell carcinoma (HNSCC) (2 arms). Primary endpoint: Rate of Disease Control at 1 year. Status: unknown.

02

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on NCT02353260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02353260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call